跳至主要内容
临床试验/ITMCTR2000003906
ITMCTR2000003906
尚未招募
未知

Clinical study on the treatment of cough variant asthma of liver-fire invading lung type by adding Chaiqinzhijie decoction

概览

阶段
未知
干预措施
未指定
疾病 / 适应症
未指定
发起方
The Second Hospital of Tianjin Medical University
状态
尚未招募
最后更新
3年前

概览

简要总结

暂无简介。

注册库
who.int
开始日期
待定
结束日期
待定
最后更新
3年前
研究类型
Interventional study
性别
All

研究者

入排标准

入选标准

  • 1\. Patients who meet the diagnostic criteria of cough variant asthma and TCM syndrome.
  • 2\. The patient's age was \> 18 years old and \< 65 years old, and the course of disease was more than 6 weeks.
  • 3\. Not taking drugs or taking the drugs specified in the guidelines for diagnosis and treatment of cough (2015\);
  • 4\. The patients who had taken traditional Chinese medicine for CVA were observed after two weeks of withdrawal;
  • 5\. After stopping inhaling glucocorticoids, bronchodilators and other drugs to reduce airway hyperresponsiveness, the patients with positive bronchodilation test and cough as the main symptoms were detected 24 hours later;
  • 6\. Patients who are willing to cooperate with this clinical study and sign informed consent.

排除标准

  • 1\. Typical asthma, esophageal reflux disease, pharyngitis, etc.
  • 2\. Pregnant or lactating women, or patients who are allergic to the drug in this study.
  • 3\. Patients with mental disorders, behavioral disorders, or severe hearing problems and who are considered to be impaired or illiterate and unable to cooperate.
  • 4\. Patients with severe pulmonary heart disease, respiratory failure or other serious organ dysfunction.
  • 5\. Patients who have used other Chinese and Western medicines for cough treatment or are participating in clinical research of other drugs after the onset of the disease.
  • 6\. Patients with poor compliance with traditional Chinese and Western medicine treatment.

结局指标

主要结局

未指定

相似试验